Antimicrobial peptides are effectors of innate immunity, providing their hosts with rapid non-specific defence against parasitic invaders. In this report, the effects are assessed of two well-characterized antimicrobial amphipathic peptides (melittin and cecropin) on human immunodeficiency virus 1 (HIV-1) replication and gene expression in acutely infected cells at subtoxic concentrations. Production of infectious, cell-free virus was inhibited in a dosedependent manner, with ID 50 values in the range 0n9-1n5 µM for melittin and 2-3 µM for cecropin. Analysis of the effect of melittin on cell-associated
Introduction
Animal peptide antibiotics are widespread in nature, occurring in mammals, amphibians and insects (Boman, 1995) . These peptides are major constituents of the innate immune system for non-specific defence of the host against microbial parasites. They can be rapidly activated after injury or invasion of the host by microbial agents, combating parasitic growth immediately after infection. Antimicrobial peptides thus provide an important defence mechanism in lower animals and the first line of host defence during the time required for mobilization of specific immunity in vertebrates.
Amphipathic cationic peptides are a major group of antimicrobial peptides and can be divided into four classes according to their structure. Genes for peptides belonging to the α-helix class have been identified in, for example, moths and mammals (cecropins), frogs (magainin) and honey bees Author for correspondence : Ruth Brack-Werner.
Fax j49 89 3187 3329. e-mail brack!gsf.de virus production revealed decreased levels of Gag antigen and HIV-1 mRNAs. Transient transfection assays with HIV long terminal repeat (LTR)-driven reporter gene plasmids indicated that melittin has a direct suppressive effect on activity of the HIV LTR. HIV LTR activity was also reduced in human cells stably transfected with retroviral expression plasmids for the melittin or cecropin gene. It is concluded that antimicrobial peptides such as melittin and cecropin are capable of inhibiting cell-associated production of HIV-1 by suppressing HIV-1 gene expression.
(melittin). Like other antimicrobial peptides, they are expressed as parts of protein precursors from which active peptides 20-40 amino acids in length are derived by serial cleavages with cellular proteases. Antimicrobial activities of cationic peptides involve disruption of bacterial membranes (Christensen et al., 1988 ; Agawa et al., 1991 ; Hancock, 1997) and possibly other non-membranolytic mechanisms (Boman et al., 1993 ; Andreu et al., 1992) . Interestingly, most cationic peptides do not induce resistance mutants in vitro and enhance antimicrobial activity of classical antibiotics in resistant bacteria, thus serving as anti-resistance compounds (Hancock, 1997) . In addition to antibacterial activities, amphipathic antimicrobial peptides have also been reported to act against fungi (Ahmad et al., 1995) , protozoa (Bevins et al., 1990) and viruses (see below).
Melittin is a 26 amino acid amphipathic α-helical peptide, which is a major component of bee venom (Habermann et al., 1967 ; Terwilliger et al., 1982 ; Bazzo et al., 1988) . The cecropins are a family of antibacterial peptides 35-39 amino acids in length which occur in a number of insect species and in mammals (Boman, 1995) . Like melittin, they consist of two α-helices linked by a flexible segment, and contain amphipathic structures. Melittin and cecropin act against a wide range of infectious agents, including Gram-positive and Gram-negative bacteria (Wade et al., 1992) . Whereas melittin is lytic for red blood cells at high concentrations, cecropins do not lyse erythrocytes or other eukaryotic cells (Wade et al., 1992 ; Steiner et al., 1981) and appear to be non-toxic for mammalian cells. Melittin has been reported to inhibit replication of murine retroviruses, tobacco mosaic virus (Marcos et al., 1995) and herpes simplex virus (Baghian et al., 1997) , suggesting that melittin also displays antiviral activity. Analogous to antibacterial activity, the antiviral activity of melittin has been attributed to direct lysis of viral membranes, as demonstrated for murine retroviruses (Esser et al., 1979) . However, melittin also displays antiviral activity at much lower, non-virolytic concentrations, as shown for T cells chronically infected with human immunodeficiency virus 1 (HIV-1) (Wachinger et al., 1992) . In this report, melittin and cecropin A are shown to suppress production of HIV-1 by acutely infected cells. Melittin treatment of T cells reduces levels of intracellular Gag and viral mRNAs, and decreases HIV long terminal repeat (LTR) activity. HIV LTR activity is also reduced in human cells stably transfected with melittin and cecropin genes. These results indicate that antimicrobial peptides such as melittin and cecropin suppress HIV-1 replication by interfering with host cell-directed viral gene expression.
Methods
Compounds. Melittin (highly purified from bee venom ; formula weight 2847) was obtained from ALK Allergologisk Laboratorium and from Bachem. Cecropin A (formula weight 4003) was obtained from Sigma. These compounds were dissolved in medium prior to application to cell cultures.
Cell lines and virus strains.
The following cell lines were used in this study : human T lymphoma cell lines KE37\1 , HUT78 (Mann et al., 1989) and chronically infected HIV-1 IIIB and RF-infected (Reitz et al., 1992) derivative cell clones KE37\1-IIIB and HUT78-RF ; human embryonic lung fibroblastoid cells LC5 (Mellert et al., 1990) and LC5-CD4, a clonal LC5 cell line transduced with an amphotropic retroviral vector containing the human CD4 receptor gene (Chesebro et al., 1990) ; and the human EJ bladder carcinoma cell line (Parada et al., 1982) .
T lymphoma and fibroblastoid cells were cultured in RPMI 1640 medium supplemented with glutamine (300 mg\l) and foetal calf serum (10 % v\v). The EJ cells were grown in DMEM supplemented with 10 % foetal calf serum. Frozen or freshly harvested culture supernatants of chronically infected T lymphoma cells served as a source of virus strains HIV-1 IIIB and HIV-1 RF. Virus suspensions were assessed for infectivity by quantifying the induction of HIV-positive syncytia in C8166 T lymphoma cells, as described (Brack-Werner et al., 1992) .
Treatment of HIV-1-infected cells with antimicrobial compounds
(i) Chronically HIV-1-infected T cells. HUT78-RF cell suspensions (100 µl) containing 8i10% cells were dispensed into microtitre plates and 100 µl culture medium containing the appropriate concentrations of melittin was added. Infectivity of culture supernatants (100 µl) was assessed 24-48 h later in LC5-CD4 indicator cells (see below).
(ii) Acutely HIV-1-infected cells. For infection of T cells, T lymphoma cells (HUT78 or KE37\1) were exposed to cell-free virus preparations (RF or IIIB) at an m.o.i. of approximately 20 for 2 h at 37 mC. HIV-inoculated cells were dispensed into microtitre plates (2i10% cells in 100 µl culture medium per well), cultured for 2 days, and 100 µl melittin-containing growth medium was added to each well. Melittin was replenished at 5 days post-infection (p.i.) by adding 100 µl fresh melittin-containing medium to each well. At 7 days p.i., infectivity of 150 µl culture supernatant was assessed by quantifying the induction of HIV-antigen positive infectious centres in LC5-CD4 cells.
For infection of fibroblastoid cells, LC5-CD4 cells were seeded into microtitre plates (3-5i10$ per well). After 24 h, cell monolayers were exposed to 100 µl virus stock at an m.o.i. of approximately 0n2 for 2-3 h. Virus suspension was removed, cells washed and culture continued with growth medium containing appropriate concentrations of melittin or cecropin. After a further 24 h, cells were assayed for HIV-antigenpositive infectious centres by indirect immunoperoxidase staining with human anti-HIV serum, as described (Mellert et al., 1990) .
The metabolic activity of cells was determined by measuring mitochondrial dehydrogenase activity, using an assay based on quantifying reduction of a colourless tetrazolium salt MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] to dark blue formazan (Mosmann, 1983 ; performed as described by Wachinger et al., 1992) .
Western blot analysis for detection of Gag antigen.
Western blot analysis was performed according to standard protocols. Cells were lysed in loading buffer (5 mM Tris-HCl pH 6n8, 2 % w\v SDS, 2n5% v\v glycerol, 0n005 % w\v bromophenol blue, 2n5% v\v β-mercaptoethanol), and heated at 95 mC for 5 min. Aliquots of cell lysates corresponding to 125 000 lysed cells were loaded on SDS-12 % w\v polyacrylamide gels. Immunostaining was carried out with a monoclonal antibody against p24 (Behring) and a peroxidase conjugate of anti-mouse IgG, using an enhanced chemoluminescence detection system (Amersham).
Quantitative RT-PCR analysis of HIV mRNAs in acutely HIV-1-infected T cells treated with melittin. KE37\1 cells were exposed to cell-free preparations of HIV-1 IIIB, propagated for 2 days and split into subcultures (5i10% cells\ml). Subcultures were expanded in the presence of various concentrations of melittin for 3 days (three cultures per melittin concentration), cells were passaged and melittin treatment continued for 2 further days (i.e. melittin treatment for a total of 5 days). Quantitative RT-PCR analysis of HIV mRNAs was performed as described (Neumann et al., 1994) . Cellular mRNAs for porphobilinogen deaminase (PBGD) were amplified as control for RNA amounts (Saltarelli et al., 1996 ; Chretien et al., 1988) . Amplification products were quantified by phospho-imaging (FUJI BAS). Levels of HIV-1 transcripts were normalized to PBGD levels. Two separate PCR analyses were performed for each cDNA preparation (12 PCR analyses per melittin concentration).
Assessment of HIV LTR activity in transient transfection assays.
HIV LTR activity in T lymphoma cells was assessed by cotransfection of pHIVLTR-CAT which contains the bacterial reporter gene chloramphenicol acetyltransferase (CAT) under the control of HIV-1 LTR (Ludvigsen et al., 1996) and TAT expression plasmid pSV2tat72 (Frankel et al., 1988) by electroporation at 250 V and 960 µF, as described (BrackWerner et al., 1992) . Electroporated cells were kept in an incubator for 2 h and then split into five subcultures for exposure to different concen- trations of melittin for 16-40 h. This procedure (batch-transfection of cells followed by subculture of aliquots of transfected cells with different concentrations of melittin) was carried out to ensure that differences in LTR activity observed with various concentrations of melittin were not due to variations in transfection efficiencies. CAT assays were performed with cell lysates containing equivalent amounts of protein, as described (Brack-Werner et al., 1992) . Acetylated and non-acetylated forms of CAT were separated by thin-layer chromatography and quantified by liquid scintillation counting or phospho-imager analysis. Percentage conversions were within the linear range of the CAT assay. LTR activities in melittin-treated cells were standardized to LTR activity in untreated cultures.
HDD EJ cells stably transfected with genes for antiviral peptides were supertransfected with 5 µg pHIVluc (Wintersperger et al., 1995) either alone or with 1 µg pSV2tat72. Cell extracts were prepared 48 h posttransfection, and equivalent amounts of protein were used for luciferase assays as outlined previously (Hornsby et al., 1992) .
Establishment of EJ cells stably transfected with prepromelittin and preprocecropin genes, respectively
(i) Expression constructs. The prepromelittin cDNA sequence from Apis mellifera was amplified by PCR from plasmid pUM13\4 (Vlasak et al., 1983) using primers 1 (5h ATAGACGTCAAGGAAGGAAGCGA-TCGGA 3h ; AatII site bold) and 2 (5h TATGGATCCAACCCTGTT-GCCTCTTACG 3h ; BamHI site bold). The preprocecropin sequence of Hyalophora cecropia was amplified from plasmid pCP9A1-2 (Lidholm et al., 1987) with primers 4 (5h TATGACGTCTCGTTAGAACGCGGCT 3h ; AatII site bold), and 5 (5h GGCAGATCTTAAATGTATCATG-CAAT 3h ; BglII site bold). For generation of retroviral expression constructs, pBag-derived plasmid p125gal (Saller, 1994 ; Price et al., 1987) was digested with AatII and BamHI to remove the β-galactosidase gene and the resulting vector fragment ligated to the prepromelittin-or preprocecropin-containing amplification products, respectively. The resulting expression plasmids contain the peptide genes under the transcriptional control of the murine leukaemia virus LTR in addition to a neomycin resistance gene driven by the SV40 early promoter.
(ii) Stable transfection and selection of G418 resistant clones. EJ cells were seeded in a 10 cm tissue culture dish at a density of 2i10' cells 1 day prior to lipofection and then lipofected with 4 µg plasmid using the lipofectamine kit from GIBCO BRL-Life Technologies, according to the manufacturer's instructions. Twenty-four h after transfection, the cells were diluted 1 : 10 and cultured in the usual medium supplemented with 400 µg\ml G418 (GIBCO BRL-Life Technologies). After 14 days, colonies of G418-resistant cell clones were visible and individual colonies isolated.
Statistical analysis.
Testing of monotone dose-response relationship was performed by the exact version of the non-parametric Jonckheere-Terpstra test (StatXact, Cytel Software) which is robust against outliers. Reported probability values are one-sided where the influence of the antimicrobial peptides could be assumed to be in only one direction, otherwise they are two-sided as stated. Values of P 0n05 are considered statistically significant.
Results

Melittin-and cecropin-dependent suppression of HIV-1 production
To evaluate antiviral activity of melittin, virus production and metabolic activity of HIV-1-infected cells treated with various concentrations of melittin were compared with untreated cultures (Fig. 1 a ; Table 1 ). Infectivity of T lymphoma cell cultures (HUT-78) was determined by exposing culture supernatants to human fibroblastoid indicator cells (LC5-CD4) and subsequent quantification of HIV immunostained infectious centres. The compiled results of numerous experiments (median values for n l 20 given in Fig. 1 a) show that production of HIV-1 by chronically HIV-1-infected T cells is decreased by treatment with melittin in a dose-dependent manner, confirming previous results (Wachinger et al., 1992) .
From these data, the ID &! was calculated as 0n4 µM (Table 1 ). The effect of melittin on virus production by acutely infected T cells was assessed by exposure of T lymphoma cells (HUT78) to cell-free preparations of HIV-1 (HIV-1 RF) and subsequent culture in the presence of various concentrations of melittin. Melittin reduced production of HIV in these acutely infected T cells in a dose-dependent manner (ID &! approximately 0n9 µM ; Table 1 ). The effect of melittin on HIV production by acutely infected fibroblasts was assayed by directly quantitating infectious centres in LC5-CD4 cultures treated with various concentrations of melittin after exposure to HIV-1. Again, a dose-dependent decrease of the number of HIV-infectious centres was observed, yielding an ID &! of 1n5 µM (Table 1 ). These results demonstrate that the HIVinhibitory effect of melittin is not T cell-specific. The cells appear to vary somewhat in their tolerance to melittin, the acutely infected T cells being most sensitive to toxic effects of melittin. However, in all cell lines the peptide concentrations required for ID &! were well within the non-toxic range (metabolic activity 85 % of control cultures, Table 1 ).
The amphipathic antimicrobial peptide cecropin was also evaluated for its anti-HIV activity. Treatment of acutely HIVinfected fibroblastoid cells with cecropin A resulted in dosedependent decrease of HIV-infectious centres (Fig. 1 b) and a calculated ID &! in the range 2-3 µM (Table 1) . Interestingly, different cecropins varied in their capacity to inhibit HIV infectivity in this assay, cecropin A being more effective than cecropin P1, and cecropin B lacking HIV-inhibitory activity (data not shown).
These results demonstrate that treatment of HIV-infected cells with increasing concentrations of melittin or cecropin suppresses production of infectious HIV. The dose-effect relationship was shown to be highly significant for both peptide compounds (P 0n0001 ; Jonckheere-Terpstra test).
Melittin-induced suppression of HIV-1 intracellular protein and mRNA synthesis
The effect of melittin on intracellular production of HIV-1 Gag proteins was analysed in T lymphoma cells (KE37\1) acutely infected with HIV-1 IIIB and cultured with various concentrations of melittin (Fig. 2) . Immunoblot analysis of cell lysates revealed decreased levels of Gag antigen in cells cultured with 1n05 and 1n4 µM melittin, compared to controls without melittin. These results indicate that melittin suppresses intracellular production of HIV structural proteins.
To determine whether melittin affects production of HIV-1 transcripts, HIV mRNAs were assayed in acutely infected T cells cultured with various concentrations of melittin. Previously described RT-PCR technology (Neumann et al., 1994) was used, enabling detection and quantification of the individual mRNA species produced in HIV-infected cells by amplification with primer pairs specific for each transcript class (large, intermediate and small). Wade et al. (1992) .
‡ Cytolytic activity was determined by erythrocyte lysis assay using sheep red blood cells (Steiner et al., 1981) . Culture of acutely HIV-1-infected T lymphoma cells with various concentrations of melittin did not lead to loss of any HIV-1 transcript species (data not shown), suggesting that melittin does not grossly alter utilization of HIV-1 splice sites. For quantification, HIV-1 mRNAs of each transcript class were normalized to the constitutively expressed form of the single copy gene for PBGD (Chretien et al., 1988) . No melittindependent reduction of mRNA levels of PBGD (Fig. 3 a) or actin (data not shown) was observed, indicating that melittin does not inhibit expression of cellular housekeeping genes.
Levels of all HIV-1 transcript classes were suppressed in a dose-dependent manner by melittin (Fig. 3 a) . The doseresponse relationship was statistically significant for all HIV-1 transcript classes (large, P l 0n0028 ; intermediate, P l 0n0034 ; small, P l 0n0437) and for overall HIV-1 transcript levels (P l 0n0045). Treatment of HIV-infected cells with 1n4 µM melittin led to a reduction of total HIV-1 mRNA levels to approximately 30 % of HIV transcript levels in cells cultured without melittin. Synthesis of large and intermediate transcripts appeared to be suppressed to a greater extent than that of small transcripts (Fig. 3 a) . In agreement, the calculated ratio of (large) : (intermediatejsmall) transcripts decreased from 1n9 to 0n7 (P l 0n0078) and that of (largejintermediate) : (small) transcripts decreased from 4n5 to 1n7 (P l 0n011) between 0 and 1n4 µM melittin.
Suppression of HIV-1 LTR activity by antimicrobial peptides
Melittin-dependent reduction of overall levels of HIV-1 mRNAs suggested inhibition of LTR activity. Therefore, we investigated the effect of melittin on HIV LTR activity by assaying CAT reporter gene activity in T lymphoma cells cotransfected with an HIV-1 LTR-driven CAT plasmid and an HIV-1 tat-expression plasmid and subsequently cultured with various concentrations of melittin. Transfection assays were performed with uninfected and HIV-producer T lymphoma cells.
Melittin treatment reduced levels of CAT activity in a dose-dependent manner (Fig. 3 b) . This effect was evident both in uninfected and in chronically HIV-1-infected T cells (data not shown) in several independent transfection experiments. The dose-response relationship was highly significant (P 0n0001). In transfected cells cultured with 1n4 µM melittin, levels of CAT activity were reduced to about 30 % of control cultures without melittin. CAT activity was not reduced significantly in cells transfected with an SV40 early promoterdriven CAT plasmid (Fig. 3 b) , suggesting that melittin does not inhibit the SV40 early gene promoter. To determine whether genes encoding antimicrobial peptides can direct inhibition of HIV LTR activity in human cells, melittin and cecropin expression plasmids were stably transfected into human cells and HIV LTR activities were assayed in these cells. For this purpose, cDNA encoding prepromelittin or preprocecropin A was inserted into a retroviral expression plasmid. Each construct (including pBag as negative control) was transfected into EJ human bladder carcinoma cells and G418-resistant cell clones were established. Cell clones were assessed for presence of the antimicrobial peptide genes by PCR and for MLV promoter-directed expression of mRNA by S1 analysis (data not shown). HIV-1 LTR activity was analysed by transient supertransfection with an HIV LTR luciferase reporter gene construct. Levels of luciferase activity were compared with a control cell clone containing pBag. To assess the effect of Tat, parallel supertransfections were carried out with and without a tatexpression plasmid.
As demonstrated in Fig. 4 , HIV LTR activity in cell clones containing antimicrobial peptides (EJppm1, EJppCA10n8) clearly decreased relative to the control cell clone containing the plasmid vector pBag (EJpBag3) or parent EJ cells. Average inhibition was similar for the melittin-and cecropin-containing clones (reduction to 20 % in three and four independent supertransfection experiments, respectively). The decrease in HIV LTR activity was not significantly affected by expression of Tat, suggesting that the mechanism by which antimicrobial peptides reduces HIV LTR activity is Tat-independent. 
Discussion
The data presented here demonstrate that melittin and cecropin exhibit a dose-dependent inhibitory effect on production of HIV by infected T cells and fibroblasts in vitro. Reduced infectivity is concomitant with decreased intracellular synthesis of HIV gene products and reduced LTR activity. Concentrations at which melittin displays antiviral activity are not cytotoxic (Table 1) and do not reduce infectivity of cellfree virus stocks (Wachinger et al., 1992) . These results indicate that the anti-HIV activity of these amphipathic peptides is not due to lysis of cellular or viral membranes. Rather, these peptides appear to interfere with the cellular capacity to support HIV replication by suppressing HIV transcription and reducing overall levels of viral gene products.
Melittin treatment reduced HIV gene expression without significantly affecting production of the cellular housekeeping gene PBGD or transcriptional activity of the SV40 early promoter (Fig. 3) . This suggests that melittin is capable of selectively inhibiting HIV gene expression under conditions where expression of other genes remains unaffected. The decline in overall levels of HIV mRNAs achieved with 1n05 and 1n4 µM melittin paralleled the decline of HIV LTR activities, suggesting a reduction of HIV transcript levels by suppression of HIV LTR activity. Melittin appears to suppress HIV LTR activity in a Tat-independent manner, indicating that melittin influences cellular transcription factors of the HIV LTR. As a membrane-active peptide, melittin is capable of interfering with cellular signal transduction pathways in different ways, including activation of phospholipase A2 (Clark et al., 1987 ; Sharma, 1993) , and decreasing activities of calmodulin (Fisher et al., 1994) and protein kinase C (Gravitt et al., 1994) . These properties may change the balance and activities of cellular stimulators of HIV transcription, such as NFκB, AP-1 and NFAT (Makropoulos et al., 1996 ; Hoover et al., 1996 ; Hill & Treisman, 1995 ; Crabtree, 1989 ; Gaynor, 1992) or induce inhibitory factors, analogous to the interferon-induced cellular inhibitor of HIV transcription (Tissot & Mechti, 1995) . In addition, melittin may interfere with post-transcriptional regulation of HIV gene expression, since levels of large and intermediate classes of mRNAs were reduced to a greater extent than small mRNAs (Fig. 3 a) . Involvement of HIV-1 Rev in regulation of large and intermediate mRNAs opens the possibility that melittin may interfere with Rev function. Thus, melittin treatment appears to suppress HIV-1 gene expression at several different levels, suggesting that genes for antimicrobial peptides may be useful for intracellular immunization against HIV. Preliminary observations suggest that melittin inhibits replication of other retroviruses, such as murine leukaemia viruses (Ammentorp, 1994 ; D. Winder, unpublished results) and feline immunodeficiency viruses (Rauer, 1994) . Further studies are required to address the specificity and conditions of inhibition of gene expression of other viruses by antimicrobial peptides.
The function of the innate immune system is to provide immediate defence against infectious invaders and to instruct the acquired immune response for long-range protection (Fearon et al., 1996) . In mammals, constituents of innate immunity include the complement system and its activators, such as C-reactive protein, natural killer cells, cytokines and intracellular antimicrobial compounds such as defensins. Innate immunity is important in protecting not only against bacterial pathogens, but also against viruses. This is underlined by the fact that some viruses have evolved mechanisms to at least partially escape initial eradication by innate immunity (Sparer et al., 1996 ; Smith, 1996) . Inhibition of HIV gene expression by melittin and cecropin suggests that the innate immune system may include an antiviral pathway for rapid defence against virus spread by curbing intracellular virus replication. Similar mechanisms could be involved in suppressing HIV production in cells with limited or no HIV replication (Brack-Werner et al., 1992 ; McCune, 1995 ; Pomerantz et al., 1992) and in suppression of HIV transcription by a factor produced by CD8 + cells in HIV-infected individuals (Mackewicz et al., 1995) , suggesting the natural occurrence of cell-directed anti-HIV mechanisms. Such mechanisms may be especially important in the case of HIV, which has been shown to be protected by serum factors from complement-dependent lysis (Stoiber et al., 1996) . Thus, concomitant with immediate defence mechanisms against bacterial invaders, the innate immune system may have evolved multiple pathways for rapid antiviral defences.
